These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 2193179)
1. Expression of human epidermal growth factor and its receptor in esophageal cancer. Mukaida H; Yamamoto T; Hirai T; Toi M; Nakamura T; Wada T; Yamashita Y; Kawano K; Niimoto M Jpn J Surg; 1990 May; 20(3):275-82. PubMed ID: 2193179 [TBL] [Abstract][Full Text] [Related]
2. Clinical significance of the expression of epidermal growth factor and its receptor in esophageal cancer. Mukaida H; Toi M; Hirai T; Yamashita Y; Toge T Cancer; 1991 Jul; 68(1):142-8. PubMed ID: 2049734 [TBL] [Abstract][Full Text] [Related]
3. Human epidermal growth factor in gastric carcinoma as a biologic marker of high malignancy. Tahara E; Sumiyoshi H; Hata J; Yasui W; Taniyama K; Hayashi T; Nagae S; Sakamoto S Jpn J Cancer Res; 1986 Feb; 77(2):145-52. PubMed ID: 2420773 [TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical and oncogenetic analyses of the esophageal basaloid squamous cell carcinoma in comparison with conventional squamous cell carcinomas. Imamhasan A; Mitomi H; Saito T; Hayashi T; Takahashi M; Kajiyama Y; Yao T Hum Pathol; 2012 Nov; 43(11):2012-23. PubMed ID: 22607702 [TBL] [Abstract][Full Text] [Related]
5. [Expression of the epidermal growth factor receptor in esophageal cancer]. Mukaida H; Hirai T; Toi M; Nakamura T; Yamashita Y; Kawano K; Toge T; Niimoto M; Hattori T Gan No Rinsho; 1989 Oct; 35(12):1399-406. PubMed ID: 2681876 [TBL] [Abstract][Full Text] [Related]
6. Epidermal growth factor receptor is a prognosis predictor in patients with esophageal squamous cell carcinoma. Zhang W; Zhu H; Liu X; Wang Q; Zhang X; He J; Sun K; Liu X; Zhou Z; Xu N; Xiao Z Ann Thorac Surg; 2014 Aug; 98(2):513-9. PubMed ID: 24881860 [TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical localization of epidermal growth factor (EGF) and EGF receptor in human oral mucosa and its malignancy. Shirasuna K; Hayashido Y; Sugiyama M; Yoshioka H; Matsuya T Virchows Arch A Pathol Anat Histopathol; 1991; 418(4):349-53. PubMed ID: 2024456 [TBL] [Abstract][Full Text] [Related]
8. Epidermal growth factor receptor overexpression in esophageal carcinoma. An immunohistochemical study correlated with clinicopathologic findings and DNA amplification. Itakura Y; Sasano H; Shiga C; Furukawa Y; Shiga K; Mori S; Nagura H Cancer; 1994 Aug; 74(3):795-804. PubMed ID: 8039107 [TBL] [Abstract][Full Text] [Related]
9. Immunohistologic detection of the epidermal growth factor receptor in human esophageal squamous cell carcinoma. Yano H; Shiozaki H; Kobayashi K; Yano T; Tahara H; Tamura S; Mori T Cancer; 1991 Jan; 67(1):91-8. PubMed ID: 1702347 [TBL] [Abstract][Full Text] [Related]
10. Concomitant analysis of the epidermal growth factor receptor family in esophageal cancer: overexpression of epidermal growth factor receptor mRNA but not of c-erbB-2 and c-erbB-3. Friess H; Fukuda A; Tang WH; Eichenberger A; Furlan N; Zimmermann A; Korc M; Büchler MW World J Surg; 1999 Oct; 23(10):1010-8. PubMed ID: 10512940 [TBL] [Abstract][Full Text] [Related]
11. TGF-alpha immunoreactivity in laryngeal carcinoma: lack of prognostic value and correlation to EGF-receptor expression. Lee CS; Redshaw A; Boag G Aust N Z J Surg; 1996 Jul; 66(7):464-8. PubMed ID: 8678876 [TBL] [Abstract][Full Text] [Related]
12. EGF and TGF-alpha, the ligands of hyperproduced EGFR in human esophageal carcinoma cells, act as autocrine growth factors. Yoshida K; Kyo E; Tsuda T; Tsujino T; Ito M; Niimoto M; Tahara E Int J Cancer; 1990 Jan; 45(1):131-5. PubMed ID: 2298497 [TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of epidermal growth factor receptor in esophageal squamous cell carcinomas. Ozawa S; Ueda M; Ando N; Shimizu N; Abe O Cancer; 1989 Jun; 63(11):2169-73. PubMed ID: 2720567 [TBL] [Abstract][Full Text] [Related]
14. Epidermal growth factor receptor immunoreactivity in human laryngeal squamous cell carcinoma. Lee CS; Redshaw A; Boag G Pathology; 1997 Aug; 29(3):251-4. PubMed ID: 9271009 [TBL] [Abstract][Full Text] [Related]
15. Clinical effect of E-series of prostaglandin receptor 2 and epidermal growth factor receptor signal pathways in the development of esophageal squamous cell carcinoma. Xu KK; Tian F; Chang D; Gong M; Fan JQ; Wang TY Dis Esophagus; 2014; 27(4):388-95. PubMed ID: 24883443 [TBL] [Abstract][Full Text] [Related]
16. Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome. Wang KL; Wu TT; Choi IS; Wang H; Resetkova E; Correa AM; Hofstetter WL; Swisher SG; Ajani JA; Rashid A; Albarracin CT Cancer; 2007 Feb; 109(4):658-67. PubMed ID: 17211865 [TBL] [Abstract][Full Text] [Related]
17. Expression of epidermal growth factor receptor and CD44 splicing variants sharing exons 6 and 9 on gastric and esophageal carcinomas: a two-color flow-cytometric analysis. Koyama S; Maruyama T; Adachi S J Cancer Res Clin Oncol; 1999; 125(1):47-54. PubMed ID: 10037277 [TBL] [Abstract][Full Text] [Related]
18. Retinoblastoma-protein (prb) expression and prognosis in squamous-cell carcinomas of the esophagus. zur Hausen A; Sarbia M; Heep H; Willers R; Gabbert HE Int J Cancer; 1999 Dec; 84(6):618-22. PubMed ID: 10567909 [TBL] [Abstract][Full Text] [Related]
19. Prognostic value of EGFR family expression in lymph node-negative esophageal squamous cell carcinoma patients. Yu W; Yang X; Chu L; Zhao K; Chen H; Xiang J; Zhang Y; Li H; Zhao W; Sun M; Wei Q; Fu X; Xie C; Zhu Z Pathol Res Pract; 2018 Jul; 214(7):1017-1023. PubMed ID: 29729836 [TBL] [Abstract][Full Text] [Related]
20. Expression, regulation and clinical significance of bone morphogenetic protein 6 in esophageal squamous-cell carcinoma. Raida M; Sarbia M; Clement JH; Adam S; Gabbert HE; Höffken K Int J Cancer; 1999 Sep; 83(1):38-44. PubMed ID: 10449605 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]